Condition: Kidney Failure, Acute · Myopathy; Drugs · Heart Arrhythmia · Sponsor: 4th Military Clinical Hospital with Polyclinic, Poland
The study aims to improve the safety of the electroporation ablation (PFA) procedure by using muscle relaxants to reduce skeletal muscle damage during the procedure. It will also assess myocardial damage to improve the procedure's quality and speed up recovery after the procedure.
This description comes directly from the study's public registry record.
Marek Szamborski, MD · 698-448-639 · mszamborski@4wsk.pl
Always discuss trial participation with your own doctor first.
| 4th Military Clinical Hospital with Polyclinic | Wroclaw, Lower Silesian Voivodeship, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06707532